CD164 Protein (CD164) (AA 24-162) (Fc Tag)

Produktnummer ABIN7274214

Produktdetails

Target: CD164

Protein-Typ: Recombinant

Proteineigenschaft: AA 24-162

Spezies: Human

Quelle: HEK-293 Cells

Aufreinigungstag / Konjugat: Dieses CD164 Protein ist gelabelt mit Fc Tag.

Verwendungszweck: Human CD164 Protein

Sequenz: Asp24-Asp162

Produktmerkmale: Recombinant Human CD164 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Asp24-Asp162.

Reinheit: > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC

Sterilität: 0.22 μm filtered

Endotoxin-Niveau: Less than 1EU per μg by the LAL method.

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

Buffer: Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Haltbarkeit: 12 months

Antigendetails

Target: CD164

Andere Bezeichnung: CD164 (CD164 Produkte)

Synonyme: MGC-24 Protein, MUC-24 Protein, endolyn Protein, CD164 Protein, MGC-24v Protein, fb75f06 Protein, fj87f10 Protein, wu:fb75f06 Protein, wu:fj87f10 Protein, si:ch211-51a19.2 Protein, A115 Protein, A24 Protein, AA589639 Protein, AW540279 Protein, MSSP Protein, CD164 molecule Protein, CD164 molecule, sialomucin Protein, CD164 antigen Protein, CD164 Protein, Cd164 Protein, cd164 Protein

Hintergrund: CD164 was found to play a role in many malignant diseases. CD164 was associated with clinical and pathological features of patients. High level of CD164 was related to the distant metastasis and vascular invasion of bladder cancer patients.CD164 was associated with the poor clinical outcomes of BC patients. Silencing of CD164 could inhibit the progression of tumors in vivo and in vitro, which may become an effective target in the treatment of bladder cancer.

Molekulargewicht: 41.2 kDa. Due to glycosylation, the protein migrates to 110-115 kDa based on Tris-Bis PAGE result.